Lantheus Holdings Debt to Equity Ratio 2013-2019 | LNTH

Current and historical debt to equity ratio values for Lantheus Holdings (LNTH) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Lantheus Holdings debt/equity for the three months ending September 30, 2019 was 1.84.
Lantheus Holdings Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2019-09-30 $0.19B $0.10B 1.84
2019-06-30 $0.19B $0.09B 2.05
2019-03-31 $0.26B $0.08B 3.16
2018-12-31 $0.26B $0.07B 3.71
2018-09-30 $0.26B $0.06B 4.76
2018-06-30 $0.27B $0.05B 5.94
2018-03-31 $0.27B $0.03B 7.87
2017-12-31 $0.27B $0.02B 11.40
2017-09-30 $0.27B $-0.08B -3.41
2017-06-30 $0.27B $-0.09B -3.05
2017-03-31 $0.27B $-0.10B -2.63
2016-12-31 $0.27B $-0.11B -2.58
2016-09-30 $0.30B $-0.12B -2.43
2016-06-30 $0.35B $-0.17B -2.10
2016-03-31 $0.35B $-0.17B -2.01
2015-12-31 $0.35B $-0.19B -1.89
2015-09-30 $0.35B $-0.19B -1.84
2015-06-30 $0.35B $-0.20B -1.79
2015-03-31 $0.00B 0.00
2014-12-31 $0.00B 0.00
2014-09-30 $0.00B 0.00
2014-06-30 $0.00B 0.00
2013-12-31 $0.40B $-0.24B -1.69
2012-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.632B $0.343B
Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations, radiopharmacies and wholesalers. Lantheus Holdings, Inc. is based in NORTH BILLERICA, United States.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $149.251B 20.06
Abbott Laboratories (ABT) United States $149.239B 26.12
Stryker (SYK) United States $80.740B 26.10
Boston Scientific (BSX) United States $57.258B 25.84
Baxter (BAX) United States $45.710B 27.72
Zimmer Biomet Holdings (ZBH) United States $31.854B 19.61
EssilorLuxottica Societe Anonyme (ESLOY) France $31.515B 0.00
Lonza Group Ag (LZAGY) Switzerland $30.964B 0.00
Coloplast (CLPBY) Denmark $29.419B 45.40
Terumo (TRUMY) Japan $25.512B 31.84
ResMed (RMD) United States $24.560B 42.67
Smith & Nephew SNATS (SNN) United Kingdom $21.404B 0.00
Sunny Optical Technology (SNPTF) China $17.754B 0.00
Insulet (PODD) United States $12.816B 609.73
Bio-Rad Laboratories (BIO) United States $11.534B 53.89
Perrigo (PRGO) Ireland $8.059B 15.03
William Demant Holdings (WILYY) Denmark $7.896B 0.00
GN STORE NORD (GNNDY) Denmark $7.537B 38.94
DiaSorin S.p.A (DSRLF) Italy $7.161B 0.00
Canopy Growth (CGC) Canada $7.092B 0.00
Hill-Rom Holdings (HRC) United States $6.919B 19.90
Haemonetics (HAE) United States $5.775B 35.54
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
Envista Holdings (NVST) United States $4.337B 0.00
ICU Medical (ICUI) United States $4.333B 28.25
NuVasive (NUVA) United States $3.821B 29.55
Neogen (NEOG) United States $3.733B 62.12
GW Pharmaceuticals (GWPH) United Kingdom $3.729B 0.00
Agios Pharmaceuticals (AGIO) United States $3.403B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.335B 0.00
Quidel (QDEL) United States $3.310B 29.06
National Vision Holdings (EYE) United States $2.727B 61.55
Aurora Cannabis (ACB) Canada $1.812B 0.00
AtriCure (ATRC) United States $1.520B 0.00
TG Therapeutics (TGTX) United States $1.518B 0.00
Cardiovascular Systems (CSII) United States $1.377B 0.00
NanoString Technologies (NSTG) United States $1.184B 0.00
InMode (INMD) Israel $1.149B 0.00
Aphria (APHA) $1.047B 0.00
Phibro Animal Health (PAHC) United States $1.045B 20.66
PetIQ (PETQ) United States $0.946B 23.07
VAREX IMAGING (VREX) United States $0.943B 19.59
Cerus (CERS) United States $0.816B 0.00
Quanterix (QTRX) United States $0.748B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.699B 26.75
Omeros (OMER) United States $0.684B 0.00
LeMaitre Vascular (LMAT) United States $0.601B 34.15
MacroGenics (MGNX) United States $0.542B 0.00
Surmodics (SRDX) United States $0.498B 57.23
Owens & Minor (OMI) United States $0.439B 16.23
Zynex (ZYXI) United States $0.437B 49.48
Organigram Holdings (OGI) Canada $0.408B 0.00
OraSure Technologies (OSUR) United States $0.381B 47.46
HEXO (HEXO) $0.372B 0.00
Utah Medical Products (UTMD) United States $0.356B 25.29
Meridian Bioscience (VIVO) United States $0.335B 13.47
BioLife Solutions (BLFS) United States $0.323B 131.42
Female Health (VERU) United States $0.281B 0.00
Repro-Med Systems (KRMD) United States $0.276B 0.00
Bovie Medical (APYX) United States $0.247B 0.00
InfuSystems Holdings (INFU) United States $0.217B 1093.00
Cytosorbents (CTSO) United States $0.210B 0.00
Rockwell Medical (RMTI) United States $0.207B 0.00
Vapotherm (VAPO) United States $0.202B 0.00
Viemed Healthcare (VMD) United States $0.197B 20.72
Neptune Wellness Solutions (NEPT) Canada $0.182B 0.00
United Health Products (UEEC) United States $0.181B 0.00
Liberty Health Sciences (LHSIF) Canada $0.163B 0.00
Fonar (FONR) United States $0.130B 9.45
Green Organic Dutchman Holdings (TGODF) Canada $0.124B 0.00
Surface Oncology (SURF) United States $0.110B 0.00
Chimerix (CMRX) United States $0.106B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
MTech Acquisition (KERN) United States $0.078B 0.00
United-Guardian (UG) United States $0.075B 18.88
Chembio Diagnostics (CEMI) United States $0.071B 0.00
Nephros (NEPH) United States $0.071B 0.00
FSD PHARMA INC (HUGE) Canada $0.046B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
NF Energy Saving (BIMI) China $0.035B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
GUARDION HEALTH (GHSI) United States $0.022B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.015B 0.00
Senestech (SNES) United States $0.006B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
Myomo (MYO) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00